Alterations in cardiac structure and function in a modified rat model of myocardial hypertrophy

Abstract

This study was aimed to establish a stable animal model of left ventricular hypertrophy (LVH) to provide theoretical and experimental basis for understanding the development of LVH. The abdominal aorta of male Wistar rats (80–100 g) was constricted to a diameter of 0.55 mm between the branches of the celiac and anterior mesenteric arteries. Echocardiography using a linear phased array probe was performed as well as pathological examination and plasma B-type natriuretic peptide (BNP) measurement at 3, 4 and 6 weeks after abdominal aortic constriction (AAC). The results showed that the acute mortality rate (within 24 h) of this modified rat model was 8%. Animals who underwent AAC demonstrated significantly increased interventricular septal (IVS), LV posterior wall (LVPWd), LV mass index (LVMI), cross-sectional area (CSA) of myocytes, and perivascular fibrosis; the ejection fraction (EF), fractional shortening (FS), and cardiac output (CO) were consistently lower at each time point after AAC. Notably, differences in these parameters between AAC group and sham group were significant by 3 weeks and reached peaks at 4th week. Following AAC, the plasma BNP was gradually elevated compared with the sham group at 3rd and 6th week. It was concluded that this modified AAC model can develop LVH, both stably and safely, by week four post-surgery; echocardiography is able to assess changes in chamber dimensions and systolic properties accurately in rats with LVH.

Keywords

abdominal aortic constriction / myocardial hypertrophy / echocardiography / rat

References

[1] BoluytMO, RobinsonKG, MeredithAL, et al.. Heart failure after long-term supravalvular aortic constriction in rats. Am J Hypertens, 2005, 18(2Pt1): 202-212

[2] MolinaEJ, GuptaD, PalmaJ, et al.. Novel experimental model of pressure overload hypertrophy in rats. J Surg Res, 2009, 153(2): 287-294

[3] CantorEJ, BabickAP, VasanjiZ, et al.. A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload. J Mol Cell Cardiol, 2005, 38(5): 777-786

[4] XuR, LinF, ZhangS, et al.. Signal pathways involved in reverse remodeling of the hypertrophic rat heart after pressure unloading. Int J Cardiol, 2010, 143(3): 414-423

[5] KompaAR, WangBH, PhrommintikulA, et al.. Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy. Peptides, 2010, 31(8): 1523-1530

[6] ShahKB, DudaMK, O’SheaKM, et al.. The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: role of cardiac phospholipid remodeling. Hypertension, 2009, 54(3): 605-611

[7] KokuboM, UemuraA, MatsubaraT, et al.. Noninvasive evaluation of the time course of change in cardiac function in spontaneously hypertensive rats by echocardiography. Hypertens Res, 2005, 28(7): 601-609

[8] PandeyKN. Biology of natriuretic peptides and their receptors. Peptides, 2005, 26(6): 901-932

[9] GuJ, D’AndreaM, SeethapathyM, et al.. Physical overdistension converts ventricular cardiomyocytes to acquire endocrine property and regulate ventricular atrial natriuretic peptide production. Angiology, 1991, 42(3): 173-186

[10] PhrommintikulA, TranL, KompaA, et al.. Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. Am J Physiol Heart Circ Physiol, 2008, 294(4): H1804-H1814

[11] OnoK, MasuyamaT, YamamotoK, et al.. Echo doppler assessment of left ventricular function in rats with hypertensive hypertrophy. J Am Soc Echocardiogr, 2002, 15(2): 109-117

[12] SahnDJ, DeMariaA, KissloJ, et al.. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation, 1978, 58(6): 1072-1083

[13] DoserTA, TurdiS, ThomasDP, et al.. Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation, 2009, 119(14): 1941-1949

[14] ShenYT, MalikFI, ZhaoX, et al.. Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure. Circ Heart Fail, 2010, 3(4): 522-527

[15] NaderL, LahoudL, ChoueryE, et al.. B-type natriuretic peptide receptors in hypertrophied adult rat cardiomyocytes. Ann Cardiol Angeiol (Paris), 2010, 59(1): 20-24

[16] RuettenH, DimmelerS, GehringD, et al.. Concentric left ventricular remodeling in endothelial nitric oxide synthaseknockout mice by chronic pressure overload. Cardiovasc Res, 2005, 66(3): 444-453

[17] HeyenJR, BlasiER, NikulaK, et al.. Structural, functional, and molecular characterization of the SHHF model of heartfailure. Am J Physiol Heart Circ Physiol, 2002, 283(5): H1775-H1784

[18] NambaT, TsutsuiH, TagawaH, et al.. Regulation of fibrillar collagen gene expression and protein accumulation involume-overloaded cardiac hypertrophy. Circulation, 1997, 95(10): 2448-2454

[19] BeeriR, ChaputM, GuerreroJL, et al.. Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricularremodeling in ischemic mitral regurgitation. Circ Heart Fail, 2010, 3(5): 627-634

[20] YoonPO, LeeMA, ChaH, et al.. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophyand fibrosis. J Mol Cell Cardiol, 2010, 49(2): 294-303

[21] NaderL, SmayraV, JebaraV, et al.. Brain natriuretic peptide secretion in adult rat heart muscle cells: the role of calcium channels. Arch Cardiovasc Dis, 2008, 101(7–8): 459-463